SectorBiological Technology
Established Date--
Listing Date01/08/2000
ExchangeNASDAQ Stock Exchange
Full-time Employees33
Fiscal Year Ends31/12
Security TypeCommon stock
Office address128 Spring Street, Building C - Suite 500, Lexington, Massachusetts, 02421
Business
IntroductionCuris, Inc., was incorporated as a Delaware corporation in February 2000. The company is a biotechnology company focused on the development of emavusertib, an oral, small-molecule inhibitor of the interleukin -1 receptor-associated kinase.
